23:37:29 EDT Fri 22 May 2026
Enter Symbol
or Name
USA
CA



Jolt Health Inc (2)
Symbol JOLT
Shares Issued 12,728,754
Close 2026-05-21 C$ 0.06
Market Cap C$ 763,725
Recent Sedar+ Documents

Jolt Health arranges debt settlement, financing

2026-05-22 17:45 ET - News Release

Subject: Jolt Health press release Word Document

File: '\\swfile\EmailIn\20260522 142930 Attachment Jolt Press Release - Debt Settlement may 2026.docx'

NATDOCS\94104092\V-2

NATDOCS\94104092\V-2

Suite 1780, 355 Burrard Street, Vancouver, BC, V6C 2G8

NATDOCS\94104092\V-2

For Immediate Release

JOLT HEALTH INC. ANNOUNCES DEBT SETTLEMENT AND PRIVATE PLACEMENT

VANCOUVER, BC, CANADA (May 22, 2026) - Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT) (FSE: G1Q0) announces the Company and arms-length third parties and related parties have reached debt settlement agreements whereby the Company will issue 4,000,000 common shares at a price of $.10 per share for a total of $400,000, subject to a 4 month restricted hold and subject to exchange approval.

Related parties transactions account for 1,900,000 of the shares to be issued will be to 2 directors and officers, making this a related party transaction. The Company is relying upon exemptions contained in sections 5.5(a) and 5.7 (a) of MI 61-101 as the fair market value of the shares being issued to insiders is less than 25% of the market capitalization of the Company.

The Company also announces that it is undertaking a non-brokered private placement of up to 6,300,000 units at $0.05 per unit, for a total of $315,000. Each unit consists of one common share and one common share purchase warrant entitling the holder to subscribe for one additional common share for two years at a price of $0.10. Proceeds will be used for general corporate purposes.

About Jolt Health Inc.

Jolt Health Inc. (CSE - JOLT) is a life sciences company focused on healthcare, biotechnology and artificial intelligence.

For further information, please contact:

Gerald Tritt, CEO

Investor Relations

Telephone: 1 (604) 343-2977

E-mail: info@jolt-health.com

www.jolt-health.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions and industry conditions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

© 2026 Canjex Publishing Ltd. All rights reserved.